Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Altering fractionation during radiation overcomes radio-resistance in patient-derived glioblastoma cells assessed using a novel longitudinal radiation cytotoxicity assay

Radiotherapy and Oncology(2024)10.1016/j.radonc.2024.110646Source: DataRank Database

Altering fractionation during radiation overcomes radio-resistance in patient-derived glioblastoma cells assessed using a novel longitudinal radiation cytotoxicity assay is a research paper published in Radiotherapy and Oncology (2024). On theSindex it has a DataRank of 0. It has been cited 2 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access2 citations

Download PDF

Cite:

Linked data & code

gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.55)OA: greenTopics (37)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Manoj Kumar ORCID,Christian T. Stackhouse ORCID,Hasan Alrefai ORCID,Taylor L. Schanel,Benjamin M Honan

Live enrichment

PubMed:39579870 PMC:PMC11789619 OpenAlex:https://openalex.org/W4404593429

NCI NIH HHS

Grant: U01 CA223976

National Cancer Institute Cairo University

NIHCM

FWCI

0.55

Citation Percentile

0.7%

Citation Trend

2025

greenLicense: https://doi.org/10.15223/policy-004

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11789619/pdf/nihms-2048955.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0167814024043081?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0167814024043081?httpAccept=text/plain

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11789619/

Fields of Study

Glioma Diagnosis and TreatmentEffects of Radiation ExposureMathematical Biology Tumor GrowthGlioblastomaHumansRadiation ToleranceDose Fractionation, RadiationBrain NeoplasmsAnimalsMice

MeSH Terms

AnimalsBrain NeoplasmsGlioblastomaHumansRadiation ToleranceDose Fractionation, RadiationMice

Keywords

GlioblastomaCytotoxicityFractionationRadiationRadiation resistanceRadiation doseCancer researchRadiochemistryChemistryNuclear medicineMedicinePhysicsIn vitroChromatographyBiochemistryOpticsCell viabilityRadiosensitivityxenograftBtic

Altering fractionation during radiation overcomes radio-resistance in patient-derived glioblastoma cells assessed using a novel longitudinal radiation cytotoxicity assay

FAIR Checklist

Authors (11)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)